BioLife Solutions Inc BLFS
๐ Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1989-11-22 |
| Shares Out. | 48,920,000 |
| Website | biolifesolutions.com/ โ |
| Phone | 13026587581 |
| Employees | 155 |
| Revenue | $28.5M |
| Gross Profit | $18.3M |
| Net Income | $45.1M |
| Free Cash Flow | $7.2M |
| Total Assets | $447.5M |
| Total Liabilities | $27.5M |
| Equity | $420.0M |
About BioLife Solutions Inc
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
BioLife Solutions Inc is a publicly traded company under the ticker symbol BLFS on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
15 analysts (2026-09-01)

